Melatonin metabolite, N1-acetyl-N1-formyl-5-methoxykynuramine (AFMK), attenuates acute pancreatitis in the rat: In vivo and in vitro studies

Journal of Physiology and Pharmacology

Volumn 67, Issue 3, 2016, Pages 411-421

  Jaworek, Jolanta ^a   Szklarczyk, J ^a   Bonior, J ^a   Kot, M ^a   Goralska, M ^a   Pierzchalski, P ^a   Reiter, R J ^b   Czech, U ^a   Tomaszewska, R ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acute pancreatitis; Antioxidant; Apoptosis; Lipid peroxidation; Melatonin; N1 acetyl N2 formyl 5 methoxykynuramine; Tumor necrosis factor alpha

Indexed keywords

4 HYDROXYNONENAL; AMYLASE; CASPASE 3; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MELATONIN; MELATONIN DERIVATIVE; N1 ACETYL N2 FORMYL 5 METHOXYKYNURAMINE; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 4-HYDROXY-2-NONENAL; ALDEHYDE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BAX PROTEIN, RAT; CASP3 PROTEIN, RAT; KYNURAMINE; N-ACETYL-N-FORMYL-5-METHOXYKYNURENAMINE; TUMOR NECROSIS FACTOR;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PANCREAS CELL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ACUTE DISEASE; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; DRUG EFFECTS; METABOLISM; PANCREAS; PANCREATITIS; PATHOLOGY; TUMOR CELL LINE; WISTAR RAT;

ACUTE DISEASE; ALDEHYDES; AMYLASES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; GLUTATHIONE PEROXIDASE; KYNURAMINE; MALE; MALONDIALDEHYDE; MELATONIN; PANCREAS; PANCREATITIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84982992706     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Nesvaderani M, Eslick GD, Vaag D, Faraj S, Cox MR. Epidemiology, aethiology and outcomes of acute pancreatitis: A retrospective cohort study. Int J Surg 2015; 23: 68-74.
2. Feng YC, Wang M, Zhu F, Qiun RY. Study on acute recent stage pancreatitis. World J Gastroenterol 2014; 20: 16138-16145.
3. Gluszek S, Koziel D. Prevalence and progression of acute pancreatitis in the swietokrzyskie voivodeship population. Pol Przegl Chir 2012; 84: 618-625.
4. Lankish PG, Apte M, Banks PA. Acute pancreatitis. Lancet 2015; 386: 85-96.
5. Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol 2011; 17: 3888-3898.
6. Acuna-Castroviejo D, Escames G, Venegas C, et al. Extrapineal melatonin: sources, regulation and potential functions. Cell Mol Life Sci 2014; 71: 2997-3025.
7. Jaworek J, Leja-Szpak A, Bonior J, et al. Protective effect of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J Pineal Res 2003; 34: 40-52.
8. Jaworek J, Szklarczyk J, Jaworek AK, et al. Protective effect of melatonin on acute pancreatitis. Int J Inflam 2012; 2012: 173675. doi: 10.1155/2012/173675.
9. Fernandez A, Ordonez R, Reiter RJ, Gonzalez-Gallego J, Mauriz JL. Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis. J Pineal Res 2015; 59: 292-307.
10. Szabolcs A, Reiter RJ, Letoha T. Effect of melatonin on the severity of L-arginine-induced experimental pancreatitis in rats. World J.Gastroenterol 2006; 14; 12: 251-258.
11. Jaworek, J, Nawrot-Por¹bka K, Leja-Szpak, et al. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 2007; 58: 65-80.
12. Luchetti F, Canonico B, Betti M, et al. Melatonin signaling and cell protection function. FASEB J 2010; 24: 3603-3624.
13. Jaworek J, Leja-Szpak A, Kot M, et al. The role of melatonin in the pancreatic protection: could melatonin be used in the treatment of acute pancreatitis? Curr Pharm Des 2014; 20: 4834-4840.
14. Zhang HM, Zhang Y. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
15. Galano A, Medina ME, Tan DX, Reiter RJ. Melatonin and its metabolites as copper chelating agents and their role in inhibiting oxidative stress: a physiochemical analysis. J Pineal Res 2015; 58: 107-116.
16. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
17. Huai JP, Sun XC, Chen MJ, et al. Melatonin attenuates acute pancreatitis-associated lung injury in rats by modulating interleukin 22. World J Gastroenterol 2012; 18: 5122-5128.
18. Gulben K, Ozdemir H, Berberoglu U, et al. Melatonin modulates the severity of taurocholate-induced acute pancreatitis. Dig Dis Sci 2010; 55: 941-946.
19. Xu C, Wu A, Zhu H, et al. Melatonin is involved in the apoptosis and necrosis of pancreatic cancer cell line via modulating of Bcl-2/Bax balance. Biomed Pharmacother 2013; 67: 133-139.
20. Wei JY, Li MW, Zhou LL, Lu QN, He W. Melatonin induced apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation. J Pineal Res 2015; 58: 429-438.
21. Laothong U, Hiraku Y, Oikawa S, Intuyod K, Murata M, Pinlaor S. Melatonin induces apoptosis in cholangiocarcinomacell lines by activating the reactive oxygen species-mediated mitochondrial pathway. Oncol Rep 2015; 33: 1443-1449.
22. Binker MG, Cosen-Binker LI. Acute pancreatitis: the stress factors. World J Gastroenterol 2014; 20: 5801-5807.
23. Chen GY, Dai RW, Luo H, et al. Effect of percutaneous catheter drainage on pancreatic injury in rats with severe acute pancreatitis induced by sodium taurocholate. Pancreatology 2015; 15: 71-77.
24. Booth DM, Murphy JA, Mukherjee R, et al. Reactive oxygen species induced by bile acid induce apoptosis and protect against necrosis in pancreatic acinar cells. Gastroenterology 2011; 140: 2116-2125.
25. Harderland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
26. Reiter RJ, Tan DX, Galano A. Melatonin reduces lipid peroxidation and membrane fluidity. Front Physiol 2014; 5: 377.
27. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter JR. One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species. J Pineal Res 2007; 42: 28-42.
28. Ciorba MA. Indoleamine 2,3 dioxygenase in intestinal disease. Curr Opin Gastroenterol 2013; 29: 146-152.
29. Tan DX, Manchester LC, Dimascio P, Martinez GR, Prado FM, Reiter RJ. Novel rhythms of N1-acetyl-N2-formyl-5-methoxykynuramine and its precursor melatonin in water hyacinth: importance for phytoremediation. FASEB J 2007; 21: 1724-1729.
30. Galano A, Tan DX, Reiter JR. On the free radical scavenging activities of melatonin metabolites; AFMK and AMK. J Pineal Res 2013; 54: 245-257.
31. Qi W, Tan DX, Reiter RJ, et al. Melatonin reduces lipid peroxidation and tissue edema in cerulein-induced acute pancreatitis in rats. Dig Dis Sci 1999; 44: 2257-2262.
32. Carrasco C, Rodriguez AB, Pariente JA. Effect of melatonin on the oxidative damage and pancreatic antioxidant defenses in cerulein-induced acute pancreatitis in rats. Hepatobiliary Pancreat Dis Int 2014; 13: 442-446.
33. Jaworek J, Bonior J, Pierzchalski P, et al. Leptin protects the pancreas from damage induced by caerulein overstimulation by modulating cytokine production. Pancreatology 2002; 2: 89-99.
34. Szklarczyk J, Jaworek J, Czech U, Bonior, Kot M, Tomaszewska R. Bilateral vagotomy attenuates the severity of secretagogue-induced acute pancreatitis in the rat. Adv Med Sci 2014; 59: 172-177.
35. Sambrook J, Fritsch EF, Maniatis T, Nolan C. Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 1989.
36. Manchester LC, Coto-Montes A, Boga JA, et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 2015; 59: 403-419.
37. Celinski K, Konturek PC, Slomka M, et al. Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease-14 months follow up. J Physiol Pharmacol 2014: 65: 75-82.
38. Kutzler MA. Alternative methods for feline fertility control: use of melatonin to suppress reproduction. J Feline Med Surg 2015; 17: 753-757.
39. Juszczak M, Roszczyk M, Kowalczyk E, Stepniak B. The influence of melatonin receptor antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT) on melatonindependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophyseal system. In vitro and in vivo studies. J Physiol Pharmacol 2014; 65: 777-784.
40. Janjetovic Z, Nahmias ZP, Hanna S, et al. Melatonin and its metabolites ameliorate ultraviolet B-induced damage in human epidermal keratinocytes. J Pineal Res 2014; 57: 90-102.
41. Dragicevic N, Copes N, O'Neal-Moffitt G, et al. Melatonin treatment restores the mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 2011; 51: 75-86.
42. Kim TK, Kleszczynski K, Janjetovic Z, et al. Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J 2013; 27: 2742-2755.
43. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite attenuates x-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007; 42: 386-393.
44. Manda K, Ueno M, Anzai K. Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. J Pineal Res 2008; 45: 430-438.
45. Tan DX, Manchester LC, Burkhardt S, et al. N1-acetyl-N1- formyl-5-methoxy-kynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15: 2294-2296.
46. Schaefer M, Hardeland R. The melatonin metabolite N1- acetyl-N1-formyl-5-methoxy- kynuramine is a potent singlet oxygen scavenger. J Pineal Res 2009; 46: 49-52.
47. Silva SO, Rodriquez MR, Ximenes VF, Bueno-da-Silva AE, Amarante-Mendes GP, Campa A. Neutrophils as a specific target for melatonin and kynuramines; effect on cytokine release. J Neuroimmunol 2004; 156: 146-152.
48. Czechowska G, Celinski K, Korolczyk A, et al. Protective effect of melatonin against thioacetamide-induced liver fibrosis in rats. J Physiol Pharmacol 2015; 66: 567-579.
49. Chen HM, Chen JC, Ng CJ, Chiu DF, Chen MF. Melatonin reduces pancreatic prostaglandins production and protects against caerulein-induced pancreatitis. J Pineal Res 2006; 40: 34-39.
50. Ganguly K, Sharma AV, Reiter RJ, Swamakar S. Melatonin promotes angiogenesis during protection and healing of indomethacin-induced gastric ulcer: role of matrix metalloproteinase-2. J Pineal Res 2010; 49: 130-140.
51. Jung KH, Hong SW, Zheng HM, et al. Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-related factor 2 and nuclear factor-kappaB in rats. J Pineal Res 2010; 48: 239-250.
52. Mauriz JL, Collado PS, Veneroso C, Reiter RJ, Gonzalez- Gallego J. A review of the molecular aspects of melatonin anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
53. Borges LDA S, Dermargos A, DA Silva Junior EP, et al. Melatonin decreases muscular oxidative stress and inflammation induced by strenuous exercise and stimulates growth factor synthesis. J Pineal Res 2015; 58: 166-172.
54. Tian H, Zhang X, Wu C, et al. Effects of Baicalin and Octreotide on the serum TNF-alpha level and apoptosis in multiple organs of rats with severe acute pancreatitis. Inflammation 2009; 32: 191-201.
55. Mayo JC, Sainz RM, Tan DX, et al. Antiinflammatory action of melatonin and its metabolites N1-acetyl-N1-formyl-5-methoxykynuramine (AFMK), and N1-acetyl-5-methoxykynuramine (AMK) in macrophages. J Neuroimmunol 2005; 165: 139-149.
56. Leja-Szpak A, Pierzchalski P, Goralska M, et al. Kynuramines induce overexpression of heat shock proteins and M1/M2 receptors J Physiol Pharmacol 2015; 66: 711-718.
57. Harthe C, Claudy D, Dechaud H, Vivien-Roels B, Pevet P, Claustrat B. Radioimmunoassay of N1-acetyl-5-methoxykynuramine (AMK); a melatonin oxidative metabolite. Life Sci 2003; 73: 1587-1597.
58. Silva SO, Ximenes VF, Livramento JA, Catalani LH, Campa A. High concentration of melatonin metabolite N1-acetyl-N1-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res 2005; 39: 302-306.